Summary. One hundred and twenty seven consecutive and previously untreated patients with Hodgkin's disease (HD) (mean age 47 years) from the Stockholm area admitted to Radiumhemmet, Karolinska Hospital, were studied. The age-matched control group consisted of 167 healthy adults. Incorporation of [14C]-dT was measured on Day 1 in unstimulated monocyte-depleted lymphocyte cultures, and on Day 3 in cultures activated by PWM, ConA and PPD. T and B cells were enumerated by surface makers. The patients had significantly decreased relative and total T-cell counts, and the lymphocyte DNA synthesis Induced by mitogens and PPD was severely Impaired, whilst the spontaneous DNA synthesis was significantly greater than in controls. At follow-up (mean 4 years) 40 patients have died. Deceased patients showed greater spontaneous lymphocyte activation and less response to mitogen and antigen stimulation than the survivors. The 5-year survival of patients with severe lymphocyte impairment was 20%, compared to 80% for the remainder. The lymphocyte tests added prognostic information to that from clinical staging. Disregarding the lack of knowledge of the mechanisms underlying the lymphocyte impairment, we suggest that these relatively simple immunological tests should be included in the clinical evaluation of HD patients and would guide the choice of therapy. THE CURRENT REGIMENS of therapy for and impaired host defences against certain HD have produced a major decrease in the infections (Goffinett et al., 1972;  Weitzman overall death rate, with long-term relapse-& Aisenberg, 1977; Askergren & Bjorkfree survival and cure in the vast majority holm, 1980) have been noted. By better of young (< 45 years) patients with early-identification of "good prognosis" patients stage disease (Kaplan, 1980a) . However, one might be able to reduce the total some young and many elderly patients do amount of radio-and chemotherapy withnot enter complete remission, or relapse out losing the therapeutic effectiveness. shortly after termination of therapy.
In the search for new tools to classify Hence, one important task is still to HD patients, attention has been paid to identify patients at risk, leading to a more the immunodeficiency which is common in efficient primary treatment. untreated patients. Thus, delayed cutanAlong with the successful treatment with eous hypersensitivity to recall antigens intensive radio-and chemotherapy, have (Chase, 1966; Young et al., 1972 ; Holm come reports of late complications. and to sensitizing agents increased risk of acute myelocytic leu-such as dinitrochlorobenzene (Aisenberg, kaemia (Bonadonna et al., 1973; Canellos 1962; Brown et al., 1967; Eltringham & et al., 1975; Brody & Schottenfeld, 1980) Kaplan, 1973 allograft survival is prolonged (Green & Corso, 1958; Kelly et al., 1958; Miller et al., 1961) . It is also generally agreed that the in vitro T-lymphocyte proliferative response to phyto-hemagglutinin (PHA), concanavalin A (ConA), pokeweed mitogen (PWM) and allogeneic lymphocytes, is low both in untreated patients and in patients during remission (Aisenberg, 1965; Hersh & Oppenheim, 1965; Holm et al., 1967; Bjorkholm, 1978) .
In 1973 a prospective study was started to classify consecutive patients according to their pretreatment lymphocyte functions. In preliminary reports which were based on short-term follow-up of a small number of patients, the lymphocyte functions seemed to add prognostic information to that achieved by age, clinical stage and histopathology (Bjorkholm et al., 1975 (Bjorkholm et al., , 1978a 
Immunological Studies
Lymphocyte purification.-The total number of lymphocytes was counted. Defibrinated venous blood was mixed with gelatin and allowed to sediment. The leucocyte-rich supernatant was incubated with carbonyl iron, and phagocytic cells were removed with a magnet. For determination of lymphocyte subpopulations, the remaining red blood cells were removed by sedimentation through a Ficoll-Isopaque gradient. T lymphocytes are defined as E+ cells forming spontaneous rosettes with sheep red blood cells (Jondal et al., 1972) . For further details, see Holm et al. (1976) .
Lymphocyte DNA synthesis.-Lymphocytes were suspended in RPMI medium (Biocult Laboratories Ltd, Glasgow) with antibiotics and 15% pooled and heat-inactivated (56TC, 1 h) human AB serum. In the first part of the study 5 x 105 cells in a total volume of 1-5 ml were added to conical tubes with or without stimulants. Later, 105 cells in 0-15 ml were pipetted to each well of microplates (Flow Laboratories, Irvine, Ayrshire). The cells were incubated in humid air with 5% CO2 at 37°C. ).
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The reproducibility was also good when subjects were tested repeatedly over 2-7 years (Wedelin et at., 1982) . As the means and statistical variations of the indices were the same as revealed by the F-test the results were pooled.
Reagents.-PWM was purchased from Gibco, Berkeley, Cal., U.S.A. and ConA from Pharmacia Fine Chemicals AB, Upsala, Sweden. Two batches of each mitogen were used during the study. Each new batch was compared with the old one, using normal lymphocytes in a dose-response experiment to assure identical ability to activate lymphocytes. One batch of purified protein derivative (PPD; State Serum Institute, Copenhagen, Denmark) was used throughout the study.
Delayed cutaneous hypersensitivity.-The patients received an intradermal injection of 0.1 ml of PPD (2 TU) on the volar surface of the forearm. The reaction was evaluated after 48 h. The crossed diameters of the induration were measured. A mean diameter of 6 mm or more was considered positive. Lymphocytes were always collected for in vitro studies before the skin test.
Statistics
The significance of differences between mean values was tested by the t test. As a measure of association between variables, Pearson's product-moment correlation (r) was chosen.
Differences between relative numbers were tested by the X2 test. Survival curves were calculated according to the product-limit estimator (Kaplan & Meier, 1958) and differences in survival were evaluated by the Kolmogorov-Smirnov test for censored survival times (Breslow & Crowley, 1974) . The relative prognostic importance of variables were analysed using the life-table regression model (Cox, 1972) .
Total lymphocyte and E+ lymphocyte counts, as well as the percentage of E+ cells, were significantly decreased in the patients (Table II) . No correlation between age and total lymphocyte and E+ cell counts was seen in the patient group. However, in the controls total and relative E+ lymphocyte counts decreased with age (r= -0 17; P<0-05; r= -0-22; P<0-01, respectively). Total lymphocyte counts but not E+ cell counts were significantly lower in patients with constitutional symptoms (Table III) . No influence of the clinical stage on lymphocyte counts was found.
The lymphocyte response to PWM, ConA and PPD was markedly decreased and the spontaneous DNA synthesis was significantly increased in the patient group (Table II) . ConA-induced DNA synthesis declined with age in the patients (r= -0 53; P<0 001) as did the response to PWM (r= -0 33; P<0 001) but not to PPD (r= -0-16). Lymphocyte stimulation declined with age also in the controls: ConA (r=-0-46; P <0-001); PWM (10 /-tg/ml) (r= -0-32; P<0-001); PPD (r= -025; P < 0.01). The lymphocyte response to mitogens and antigen was low and the spontaneous lymphocyte activity high, in patients with B symptoms and advanced disease (Table III) . None of the immunological variables and PWM was associated at all tested concentrations (Table IV) . A less pronounced correlation between PPD and mitogen-induced DNA synthesis was observed. The spontaneous DNA synthesis showed only a weak inverse correlation with the PPD response (Table IV) . The PPD-induced DNA synthesis in vitro followed the delayed cutaneous hypersensitivity to PPD (Table V) . The number of PPD skin-positive patients was equally distributed in the different age groups. PPD anergy was more common in patients with advanced disease (Table V) . However, there was no association between B symptoms and PPD skin reactivity. The pretreatment lymphocyte counts and functions in relation to death or survival at follow-up are shown in Table  VI . Patients with a fatal outcome had poorer lymphocyte responses to mitogen and antigen stimulation than the remaining patients. Furthermore, the spontaneous DNA synthesis was markedly increased in patients with bad prognosis. Lymphocyte and E+ counts and PPD skin reactivity did not differ between the two patient groups (Table VI and data not shown).
The pretreatment spontaneous and ConA (20 ,g/ml) induced lymphocyte DNA synthesis of each patient in relation to prognosis is shown in Fig. 1 . Twentysix of 40 patients (65%) with increased spontaneous (approximately control mean + 1 s.d.) and a decreased mitogen-induced lymphocyte activity (approximately control mean -1 s.d.) had succumbed, while only 13 ofremaining 83 patients (16%) had a fatal outcome. Very similar prognostic discrimination was furnished by PWM, but not by PPD-induced lymphocyte stimulation (data not shown).
Cox's life table regression was used to evaluate the importance of clinical and immunological variables of prognosis (Table VII) (Bjorkholm et al., 1979) . Age gave the most information. Clinical stage was associated with prognosis, whilst histology and symptomatology were not. rmal spontaneous lymphocyte activity mortality in immunologically "normal" 80%, compared with 450o for the patients. Thus, the combined effect of lining patients (P < 0 01; Fig. 2 ). 7500 these two, independent variables is more Le patients with a normal lymphocyte indicative of poor prognosis than any V response lived at 5 years, whilst only other known factor. The importance of this finding is further underlined by the survival in relation to lymphocyte capacity. The results of the present study greatly extend and confirm our preliminary findings which were based on smaller patient materials for shorter observation times (Bjorkholm et al., 1975 (Bjorkholm et al., , 1978a . The results clearly demonstrate that the pretreatment blood-lymphocyte functions measured as spontaneous and mitogen (ConA and PWM)-induced DNA synthesis constitute powerful predictors of prognosis in HD.
Cell-mediated immunity is selectively impaired in virtually all untreated patients with HD (for references see Bjorkholm, 1978; Twomey & Rice, 1980) . The severity of the immunodeficiency may vary and is not necessarily related to the extent of the disease (Levy & Kaplan, 1974; Bjorkholm et al., 1978a) . During the last 15 years many studies have been focused on the nature of the immune defect, yet, the mechanisms underlying the immunological dysfunction are only partly exposed. Some facets of the immunodeficiency seem to be associated with active disease. Thus, the lymphocyte stimulation by recall antigen in vitro and in vivo, and to some extent the spontaneous lymphocyte DNA synthesis, may eventually normalize (Sokal & Primikirios, 1961; King et al., 1976; Gobbi et al., 1977; Bjorkholm et al., 1977b Bjorkholm et al., , c, 1981 . Lymphocyte inhibitory serum factors which disappear after successful treatment may contribute to the deficiency during active disease (Holm et al., 1979a, b) . On the other hand, impairment of T-lymphocyte stimulation by mitogen seems to persist in cured patients (Bjorkholm et al., 1977b Case et al., 1977) . A similar lymphocyte deficiency has also been described in healthy consanguineous and non-consanguineous relatives of HD patients (Bjorkholm et al., 1977d; 1978b) . Autoantibodies to lymphocyte subsets may play a role by lysis or opsonization leading to trapping and destruction in the spleen (Bjorkholm, 1978; De Sousa et al., 1978; Holm et al., 1979b; Bjorkholm et al., 1980) . This hypothesis has gained some support from studies of the role of the spleen in HD. Thus, in patients with tumour-engaged spleens an inverse relationship between spleen size and the lymphocyte response to PWM stimulation has been reported . Moreover, mitogen-reactive lymphocytes are also present in the spleen in patients with severe blood-lymphocyte defects (Twomey et al., 1976; Willson et al., 1977) . Imbalance in regulation by macrophages or T cells may also contribute (Twomey et al., 1975; Goodwin et al., 1977) but has not been confirmed . Disregarding its mechanisms, the degree of immunological malfunction before institution of therapy may mirror in an unspecific way the patient's ability to cope with his disease.
One can only speculate on the reason for the association between lymphocyte function and prognosis. A likely explanation would be that T-lymphocytes participate in the tumour defence. Destruction, inactivation or elimination of such cells by the spleen or by other tissues may lead to inefficient tumour defence. However, Tcells may have no bearing on tumour resistance. Rather, the persistent Tlymphocyte malfunction in HD may reflect the influence of some external factor (virus?), preexisting or acquired as a consequence of the tumour (Bjorkholm, 1978; Holm et al., 1979b) . In this case, the severity of the defect may rather mirror the aggressiveness of the tumour.
Notwithstanding the lack of knowledge on the relationship between the lymphocyte abnormalities and the disease process, we believe that lymphocyte testing may be an important tool in the clinical pretreatment evaluation to give a better basis for choice of therapy in HD. A prospective study has therefore been started, where patients are allocated to different treatment regimens according to their pretreatment; lymphocyte functions.
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